Skip to content
This GLP
Updated September 2026Tablets cost far more

Silhouette MD review

Both injections are advertised as a lowest tier. Both tablets cost substantially more and carry no such qualifier.

The verdict

Silhouette MD publishes as low as $149 a month for injected semaglutide and $299 for tirzepatide, read August 2026. The tablets are $263 and $325.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection · Oral
Injection
From $149/mo
Oral
From $263/mo
Prescription
Required
Compounded
Yes — not FDA-approved

Silhouette MD sells both molecules as an injection and as an oral. Four lines carry a figure. Only the injections are qualified.

  1. Who writes the prescription, and what do they see?

    A prescription is issued before dispensing. Nothing describes who writes it or how often a case is reviewed.

    The gap between the two routes is the useful fact. A reader choosing the tablet pays a premium of $114 or $26 depending on molecule.

  2. What happens when the dose goes up?

    Nothing published says what either injection becomes at a higher dose. The as-low-as wording implies movement without naming it.

  3. What the price includes

    Six months at $149 is $894 at best, and at $299 is $1,794. The tablets are $1,578 and $1,950 over the same period, and neither carries a lowest-tier caveat.

  4. What it claims, and what it cites

    Every line is compounded. A pharmacy prepares them. The FDA reviews none of them before they are dispensed.

Where it holds up, and where it does not

  • Strength: Four lines all carry a figure
  • Strength: Tablet prices are unqualified
  • Strength: Both molecules in both routes
  • Limitation: Both injection figures are a floor
  • Limitation: The semaglutide tablet costs $114 more
  • Limitation: No milligram published anywhere
  • Limitation: The states served are not listed

What the evidence says about this kind of treatment

The assessment above is about Silhouette MD. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A reader who wants an unqualified number and will pay the tablet premium to get one.
Wrong for
A reader assuming the tablet is the economical choice.

How Silhouette MD compares

SellerWho it suitsGo
Somi HealthReaders who want the dose question answered in writing before anything elseSee Somi Health
Pepton HealthReaders who will create an account before deciding anythingSee Pepton Health
Auren RxReaders who want tirzepatide without paying a premium for itSee Auren Rx
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: Trimi HealthTrimRxTru2uTry AgelessVirtualCare2GoVitalex Health

Sponsored alternative

Synergy Rx

A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.

Check Synergy Rx availability →

Frequently asked

Why are the tablets dearer?
The page does not say. It prices them higher and qualifies only the injections.
Is $149 a real rate?
It is the lowest advertised tier. What sits above it is unpublished.
What does six tablet months cost?
$1,578 for semaglutide and $1,950 for tirzepatide.
Is Silhouette MD expensive compared with other GLP-1 telehealth sellers?
Silhouette MD publishes a starting figure of $149/mo. Across the 188 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts Silhouette MD below the median, toward the cheaper end. The other 12 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
Glenn TorresStandards editor · Reviewed and last verified September 2026

How this was assessed. The four questions above are answered from Silhouette MD’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.